{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T06:47:25Z","timestamp":1790059645587,"version":"4.0.1"},"reference-count":80,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2001,3,1]],"date-time":"2001-03-01T00:00:00Z","timestamp":983404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2001,3,1]],"date-time":"2001-03-01T00:00:00Z","timestamp":983404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2001,3]]},"DOI":"10.1053\/beem.2000.0118","type":"journal-article","created":{"date-parts":[[2002,9,19]],"date-time":"2002-09-19T09:54:50Z","timestamp":1032429290000},"page":"43-60","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Disorders of mineralocorticoid synthesis"],"prefix":"10.1053","volume":"15","author":[{"given":"John M.C.","family":"Connell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Fraser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanor","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/beem.2000.0118_RF1","series-title":"Handbook of Hypertension","first-page":"420","article-title":"Inborn errors of corticosteroid biosynthesis and metabolism: their effects on electrolyte metabolism","author":"Fraser","year":"1992"},{"key":"10.1053\/beem.2000.0118_RF2","first-page":"421","article-title":"Disorders of 11\u03b2-hydroxylase isoenzymes","volume":"15","author":"White","year":"1994","journal-title":"Endocrine Reviews"},{"key":"10.1053\/beem.2000.0118_RF3","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1161\/01.RES.34.1.69","article-title":"Sensitization of the adrenal cortex to angiotensin II in sodium-deplete man","volume":"34","author":"Oelkers","year":"1974","journal-title":"Circulation Research"},{"key":"10.1053\/beem.2000.0118_RF4","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1172\/JCI107748","article-title":"Reciprocal influence of salt intake on adrenal glomerulosa and renal vascular reponses to angiotensin II in normal man","volume":"54","author":"Hollenberg","year":"1974","journal-title":"Journal of Clinical Investigation"},{"key":"10.1053\/beem.2000.0118_RF5","series-title":"Handbook of Physiology","first-page":"156","article-title":"Aldosterone","author":"Ganguly","year":"2000"},{"key":"10.1053\/beem.2000.0118_RF6","doi-asserted-by":"crossref","first-page":"795","DOI":"10.3109\/10641968409044039","article-title":"Blood pressure and metabolic effects of cortisol and deoxycorticosterone in man","volume":"A6","author":"Whitworth","year":"1984","journal-title":"Clinical and Experimental Hypertension\u2014Theory and Practice"},{"key":"10.1053\/beem.2000.0118_RF7","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/0026-0495(79)90201-4","article-title":"Mineralocorticoid-induced blood pressure, electrolyte and hormone changes and reversal with spironolactone","volume":"28","author":"Nicholls","year":"1979","journal-title":"Metabolism"},{"key":"10.1053\/beem.2000.0118_RF8","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1146\/annurev.physiol.59.1.365","article-title":"Specific, nongenomic actions of steroid hormones","volume":"59","author":"Wehling","year":"1997","journal-title":"Annual Review of Physiology"},{"key":"10.1053\/beem.2000.0118_RF9","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1161\/01.HYP.26.6.971","article-title":"Biological determinants of aldosterone-induced cardiac fibrosis in rats","volume":"26","author":"Robert","year":"1995","journal-title":"Hypertension"},{"key":"10.1053\/beem.2000.0118_RF10","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0960-0760(93)90142-J","article-title":"The role of vascular steroid receptors in the control of vascular contractility and peripheral vascular resistance","volume":"45","author":"Kornel","year":"1993","journal-title":"Journal of Steroid Biochemistry and Molecular Biology"},{"key":"10.1053\/beem.2000.0118_RF11","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1006\/frne.1997.0157","article-title":"Central hypertensive effects of aldosterone","volume":"18","author":"Gomez-Sanchez","year":"1997","journal-title":"Frontiers in Neuroendocrinology"},{"key":"10.1053\/beem.2000.0118_RF12","first-page":"39","article-title":"Steroids, hypertension and cardiac fibrosis","volume":"4","author":"Funder","year":"1995","journal-title":"Blood Pressure"},{"key":"10.1053\/beem.2000.0118_RF13","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1146\/annurev.med.48.1.231","article-title":"Glucocorticoid and mineralocorticoid receptors: biological and clinical relevance","volume":"48","author":"Funder","year":"1997","journal-title":"Annual Review of Medicine"},{"key":"10.1053\/beem.2000.0118_RF14","doi-asserted-by":"crossref","first-page":"C605","DOI":"10.1152\/ajpcell.1996.271.2.C605","article-title":"Aldosterone-induced increase in the abundance of sodium channel subunits","volume":"271","author":"Asher","year":"1996","journal-title":"American Journal of Physiology"},{"key":"10.1053\/beem.2000.0118_RF15","first-page":"365","article-title":"Aldosterone regulation of sodium and potassium transport in the cortical collecting duct","volume":"10","author":"O'Neill","year":"1990","journal-title":"Seminars in Nephrology"},{"key":"10.1053\/beem.2000.0118_RF16","first-page":"I-2","article-title":"The role of the anteroventral third ventricle (AV3V) region in experimental hypertension","volume":"43","author":"Brody","year":"1978","journal-title":"Circulation Research"},{"key":"10.1053\/beem.2000.0118_RF17","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/nsb0197-32","article-title":"The amino acid substitutions Ser288Gly and Val320Ala convert the cortisol producing enzyme, CYP11B1, into an aldosterone producing enzyme","volume":"4","author":"Curnow","year":"1997","journal-title":"Nature Structural Biology"},{"key":"10.1053\/beem.2000.0118_RF18","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0014-5793(90)81190-Y","article-title":"Cloning of cDNA and genomic DNA for human cytochrome P450-11b","volume":"269","author":"Kawamoto","year":"1990","journal-title":"FEBS Letters"},{"key":"10.1053\/beem.2000.0118_RF19","doi-asserted-by":"crossref","first-page":"7494","DOI":"10.1016\/S0021-9258(18)53202-6","article-title":"Ad4BP regulating steroidogenic P-450 gene is a member of steroid hormone receptor superfamily","volume":"268","author":"Honda","year":"1993","journal-title":"Journal of Biological Chemistry"},{"key":"10.1053\/beem.2000.0118_RF20","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1161\/01.CIR.97.6.569","article-title":"Association between human aldosterone synthase (CYP11B2) gene polymorphisms and left ventricular size, mass and function","volume":"97","author":"Kupari","year":"1998","journal-title":"Circulation"},{"key":"10.1053\/beem.2000.0118_RF21","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1677\/jme.0.0240321","article-title":"Expression of 11\u03b2-hydroxylase and aldosterone synthase in the rat brain","volume":"24","author":"MacKenzie","year":"2000","journal-title":"Journal of Molecular Endocrinology"},{"key":"10.1053\/beem.2000.0118_RF22","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0008-6363(99)00088-7","article-title":"Aldosterone and the heart: towards a physiological function?","volume":"43","author":"Delcayre","year":"1999","journal-title":"Cardiovascular Research"},{"key":"10.1053\/beem.2000.0118_RF23","first-page":"639","article-title":"The expression of steroidogenic enzyme genes in human vascular cells","volume":"40","author":"Hatakeyama","year":"1996","journal-title":"Biochemistry and Molecular Biology International"},{"key":"10.1053\/beem.2000.0118_RF24","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1530\/eje.0.1420187","article-title":"Autoantibodies against recombinant human steroidogenic enzymes 21-hydroxylase, side-chain cleavage and 17\u03b1-hydroxylase in Addison's disease and autoimmune polyendocrine syndrome type III","volume":"142","author":"Do Carmo Silva","year":"2000","journal-title":"European Journal of Endocrinology"},{"key":"10.1053\/beem.2000.0118_RF25","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/S0950-351X(05)80299-X","article-title":"Adrenal complications of HIV infection","volume":"8","author":"Opocher","year":"1994","journal-title":"Bailli\u00e8re's Clinical Endocrinology and Metabolism"},{"key":"10.1053\/beem.2000.0118_RF26","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1136\/bmj.1.5854.650","article-title":"Recurrent hyperkalaemia due to selective aldosterone deficiency: correction by angiotensin infusion","volume":"1","author":"Brown","year":"1973","journal-title":"British Medical Journal"},{"key":"10.1053\/beem.2000.0118_RF27","first-page":"83","article-title":"Plasma 18-hydroxycorticosterone and aldosterone responses to angiotensin II and corticotropin in diabetic patients with hyporeninemic and normoreninemic hypoaldosteronism","volume":"121","author":"Iwasaki","year":"1989","journal-title":"Acta Endocrinologica"},{"key":"10.1053\/beem.2000.0118_RF28","first-page":"1415","article-title":"The biochemical phenotypes of two inborn errors in the biosynthesis of aldosterone","volume":"74","author":"Ulick","year":"1992","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1053\/beem.2000.0118_RF29","first-page":"321","article-title":"Gene conversion in the CYP11B2 gene encoding P45011AS is associated with but does not cause the syndrome of corticosterone methyl oxidase II deficiency","volume":"81","author":"Fardella","year":"1996","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1053\/beem.2000.0118_RF30","first-page":"4156","article-title":"Isolated aldosterone synthase deficiency caused by simultaneous E198D and V386A mutations in the CYP11B2 gene","volume":"83","author":"Portrat-Doyen","year":"1998","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1053\/beem.2000.0118_RF31","first-page":"199","article-title":"A familial renal disorder simulating primary aldosteronism but with negligible aldosterone secretion","volume":"76","author":"Liddle","year":"1963","journal-title":"Transactions of the American Society of Physicians"},{"key":"10.1053\/beem.2000.0118_RF32","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1126\/science.289.5476.119","article-title":"Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy","volume":"289","author":"Geller","year":"2000","journal-title":"Science"},{"key":"10.1053\/beem.2000.0118_RF33","first-page":"6","article-title":"Primary aldosteronism, a new clinical syndrome","volume":"45","author":"Conn","year":"1955","journal-title":"Journal of Laboratory and Clinical Medicine"},{"key":"10.1053\/beem.2000.0118_RF34","first-page":"79P","article-title":"Aldosterone and its stimuli in normal and hypertensive man: are essential hypertension and primary hyperaldosteronism without tumour the same condition?","volume":"81","author":"Davies","year":"1979","journal-title":"Journal of Endocrinology"},{"key":"10.1053\/beem.2000.0118_RF35","series-title":"Handbook of Hypertension","first-page":"357","article-title":"Primary hyperaldosteronism: Conn's syndrome and similar disorders","author":"Ferriss","year":"1992"},{"key":"10.1053\/beem.2000.0118_RF36","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1365-2265.1996.tb02059.x","article-title":"Primary aldosteronism. Part I Diagnosis of primary hyperaldosteronism","volume":"45","author":"Vallotton","year":"1996","journal-title":"Clinical Endocrinology"},{"key":"10.1053\/beem.2000.0118_RF37","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1365-2265.1996.tb02060.x","article-title":"Primary aldosteronism. Part II Differential diagnosis of primary hyperaldosteronism and pseudoaldosteronism","volume":"45","author":"Vallotton","year":"1996","journal-title":"Clinical Endocrinology"},{"key":"10.1053\/beem.2000.0118_RF38","series-title":"Textbook of Hypertension","first-page":"865","article-title":"Primary aldosteronism and other forms of mineralocorticoid hypertension","author":"Gordon","year":"1994"},{"key":"10.1053\/beem.2000.0118_RF39","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1440-1681.1992.tb00462.x","article-title":"Familial hyperaldosteronism type II: five families with a new variety of primary aldosteronism","volume":"19","author":"Stowasser","year":"1992","journal-title":"Clinical and Experimental Pharmacology and Physiology"},{"key":"10.1053\/beem.2000.0118_RF40","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0039-128X(94)00013-3","article-title":"Primary aldosteronism\u2014some genetic, morphological and biological aspects of subtypes","volume":"60","author":"Gordon","year":"1995","journal-title":"Steroids"},{"key":"10.1053\/beem.2000.0118_RF41","first-page":"392","article-title":"Cellular origin of aldosteronomas","volume":"70","author":"Ganguly","year":"1992","journal-title":"Clinical Investigation"},{"key":"10.1053\/beem.2000.0118_RF42","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1161\/01.HYP.35.3.694","article-title":"CYP11B2 gene polymorphisms in idiopathic hyperaldosteronism","volume":"35","author":"Mulatero","year":"2000","journal-title":"Hypertension"},{"key":"10.1053\/beem.2000.0118_RF43","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1161\/01.HYP.33.2.703","article-title":"Aldosterone excretion rate and blood pressure in essential hypertension are related to polymorphic differences in the aldosterone synthase gene","volume":"33","author":"Davies","year":"1999","journal-title":"Hypertension"},{"key":"10.1053\/beem.2000.0118_RF44","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/355262a0","article-title":"A chimaeric 11\u03b2-hydroxylase\/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension","volume":"355","author":"Lifton","year":"1992","journal-title":"Nature"},{"key":"10.1053\/beem.2000.0118_RF45","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1136\/adc.71.1.40","article-title":"Rapid diagnosis of glucocorticoid-suppressible hyperaldosteronism in infants and adolescents","volume":"71","author":"Jamieson","year":"1994","journal-title":"Archives of Disease in Childhood"},{"key":"10.1053\/beem.2000.0118_RF46","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1440-1681.1991.tb01446.x","article-title":"Clinical and pathological diversity of primary aldosteronism including a new familial variety","volume":"18","author":"Gordon","year":"1991","journal-title":"Clinical and Experimental Pharmacology and Physiology"},{"key":"10.1053\/beem.2000.0118_RF47","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1042\/cs0880563","article-title":"Glucocorticoid-suppressible hyperaldosteronism: effects of crossover site and parental origin of chimaeric gene on phenotypic expression","volume":"88","author":"Jamieson","year":"1995","journal-title":"Clinical Science"},{"key":"10.1053\/beem.2000.0118_RF48","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/jmg.33.1.25","article-title":"Variation of phenotype in patients with glucocorticoid remediable aldosteronism","volume":"33","author":"Gates","year":"1996","journal-title":"Journal of Medical Genetics"},{"key":"10.1053\/beem.2000.0118_RF49","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1161\/01.HYP.31.1.445","article-title":"Intracranial aneurysm and hemorrhagic stroke in glucorticoid-remediable aldosteronism","volume":"31","author":"Litchfield","year":"1998","journal-title":"Hypertension"},{"key":"10.1053\/beem.2000.0118_RF50","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.7326\/0003-4819-119-11-199312010-00009","article-title":"Syndromes of glucocorticoid resistance","volume":"119","author":"Chrousos","year":"1993","journal-title":"Annals of Internal Medicine"},{"key":"10.1053\/beem.2000.0118_RF51","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1365-2265.1987.tb00782.x","article-title":"Hypermineralocorticoidism due to adrenal carcinoma: plasma corticosteroids and their response to ACTH and angiotensin II","volume":"26","author":"Isles","year":"1987","journal-title":"Clinical Endocrinology"},{"key":"10.1053\/beem.2000.0118_RF52","first-page":"3771","article-title":"Absence of steroidogenic defects in heterozygote individuals for classic 11\u03b2-hydroxylase deficiency due to a R448H mutation in the CYP11B1 gene","volume":"80","author":"Rosler","year":"1995","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1053\/beem.2000.0118_RF53","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1172\/JCI115182","article-title":"A mutation in CYP11B1 (Arg448\u2192His) associated with steroid 11\u03b2-hydroxylase deficiency in Jews of Morocco","volume":"87","author":"White","year":"1991","journal-title":"Journal of Clinical Investigation"},{"key":"10.1053\/beem.2000.0118_RF54","article-title":"Unequal crossing-over between CYP11B1 and CYP11B2 genes causing 11\u03b2-hydroxylase deficiency (CAH)","author":"Hampf","year":"2000","journal-title":"Endocrine Research"},{"key":"10.1053\/beem.2000.0118_RF55","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1210\/jcem-63-3-789","article-title":"Assignment of the gene for P450C17(steroid 17\u03b1-hydroxylase\/17,20-lyase) to human chromosome 10","volume":"63","author":"Matteson","year":"1986","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1053\/beem.2000.0118_RF56","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1172\/JCI105499","article-title":"17-Hydroxylation deficiency in man","volume":"12","author":"Biglieri","year":"1966","journal-title":"Journal of Clinical Investigation"},{"key":"10.1053\/beem.2000.0118_RF57","first-page":"667","article-title":"Compound heterogenous mutations (Arg239-stop, Pro342Thr) in the CYP17 (P450-17\u03b1) gene lead to ambiguous genitalia in a male patient with partial combined 17\u03b1-hydroxylase\/17,20-lyase deficiency","volume":"74","author":"Ahlgren","year":"1992","journal-title":"Journal of Clincial Endocrinology and Metabolism"},{"key":"10.1053\/beem.2000.0118_RF58","series-title":"Essential Hypertension as an Endocrine Disease","first-page":"158","article-title":"Role of mineralocorticoids in essential hyperaldosteronism","author":"Fraser","year":"1985"},{"key":"10.1053\/beem.2000.0118_RF59","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1042\/cs0630257","article-title":"Relation of body sodium, body potassium and plasma potassium with arterial pressure in essential hypertension","volume":"63","author":"Beretta Piccoli","year":"1982","journal-title":"Clinical Science"},{"key":"10.1053\/beem.2000.0118_RF60","series-title":"Essential Hypertension as an Endocrine Disease","first-page":"184","article-title":"Abnormal adrenal and renal responses to angiotensin II in essential hypertension","author":"Williams","year":"1982"},{"key":"10.1053\/beem.2000.0118_RF61","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1161\/01.HYP.7.2.204","article-title":"Partial deficiency of adrenal 11\u03b2-hydroxylase. A possible cause of primary hypertension","volume":"7","author":"De Simone","year":"1985","journal-title":"Hypertension"},{"key":"10.1053\/beem.2000.0118_RF62","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0140-6736(05)74868-6","article-title":"Potentially high prevalence of primary aldosteronism in a primary-care population","volume":"353","author":"Lim","year":"1999","journal-title":"Lancet"},{"key":"10.1053\/beem.2000.0118_RF63","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0140-6736(81)90424-4","article-title":"The myth of idiopathic hyperaldosteronism","volume":"ii","author":"Padfield","year":"1981","journal-title":"Lancet"},{"key":"10.1053\/beem.2000.0118_RF64","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1210\/mend.11.5.9920","article-title":"Angiotensin II and potassium regulate human CYP11B2 transcription through common cis-elements","volume":"11","author":"Clyne","year":"1997","journal-title":"Molecular Endocrinology"},{"key":"10.1053\/beem.2000.0118_RF65","unstructured":"Lim, P, O, MacDonald, T, M, Holloway, C, D, Variation at the aldosterone synthase (CYP11B2) locus contributes to hypertension in subjects with raised aldosterone to renin ratio, Lancet"},{"key":"10.1053\/beem.2000.0118_RF66","first-page":"4347","article-title":"Genetic variation in P450c11AS in Chilean patients with low renin hypertension","volume":"81","author":"Fardella","year":"1996","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1053\/beem.2000.0118_RF67","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/0006-291X(92)91827-D","article-title":"Congenitally defective aldosterone biosynthesis in humans: the involvement of point mutations of the P-450(C18) gene (CYP11B2) in CMO II deficient patients","volume":"182","author":"Mitsuuchi","year":"1992","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1053\/beem.2000.0118_RF68","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1006\/bbrc.1997.6651","article-title":"CMOI deficiency caused by a point mutation in exon 8 of the human gene CYP11B2 encoding steroid 18-hydroxylase (P450(C18))","volume":"234","author":"Nomoto","year":"1997","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1053\/beem.2000.0118_RF69","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s004310050833","article-title":"Mutation The185Ile is associated with corticosterone methyl oxidase deficiency type II","volume":"157","author":"Peter","year":"1998","journal-title":"European Journal of Pediatrics"},{"key":"10.1053\/beem.2000.0118_RF70","first-page":"424","article-title":"Amino acid substitution R384P in aldosterone synthase causes corticosterone methyl oxidase type I deficiency","volume":"80","author":"Geley","year":"1995","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1053\/beem.2000.0118_RF71","doi-asserted-by":"crossref","first-page":"4996","DOI":"10.1073\/pnas.89.11.4996","article-title":"Mutations in the human CYP11B2 (aldosterone synthase) gene causing corticosterone methyloxidase II deficiency","volume":"89","author":"Pascoe","year":"1992","journal-title":"Proceedings of the National Academy of Sciences of the USA"},{"key":"10.1053\/beem.2000.0118_RF72","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1006\/bbrc.1993.1128","article-title":"Congenitally defective aldosterone biosynthesis in humans: inactivation of the P-450(C18) gene (CYP11B2) due to nucleotide deletion in CMOI deficient patients","volume":"190","author":"Mitsuuchi","year":"1993","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1053\/beem.2000.0118_RF73","first-page":"1037","article-title":"Mutation T318M in the CYP11B2 gene encoding P450c11AS (aldosterone synthase) causes corticosterone methyloxidase II deficiency","volume":"57","author":"Zhang","year":"1995","journal-title":"American Journal of Human Genetics"},{"key":"10.1053\/beem.2000.0118_RF74","doi-asserted-by":"crossref","first-page":"4552","DOI":"10.1073\/pnas.90.10.4552","article-title":"Mutations in the CYP11B1 gene causing congenital adrenal hyperplasia and hypertension cluster in exons 6, 7 and 8","volume":"90","author":"Curnow","year":"1993","journal-title":"Proceedings of the National Academy of Sciences of the USA"},{"key":"10.1053\/beem.2000.0118_RF75","first-page":"2896","article-title":"CYP11B1 mutations causing congenital adrenal hyperplasia due to 11\u03b2-hydroxylase deficiency","volume":"81","author":"Geley","year":"1996","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1053\/beem.2000.0118_RF76","first-page":"1677","article-title":"A nonsense mutation (TGG[Trp116]\u2192TAG[stop]) in CYP11B1! causes 11\u03b2-hydroxylase deficiency","volume":"77","author":"Nakai","year":"1993","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1053\/beem.2000.0118_RF77","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/hmg\/3.2.377","article-title":"Steroid 11\u03b2-hydroxylase deficiency caused by a five base pair duplication in the CYP11B1 gene","volume":"3","author":"Skinner","year":"1994","journal-title":"Human Molecular Genetics"},{"key":"10.1053\/beem.2000.0118_RF78","first-page":"2389","article-title":"Single strand conformation polymorphism (SSCP) analysis for the detection of mutations in the CYP11B1 gene","volume":"81","author":"Skinner","year":"1996","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1053\/beem.2000.0118_RF79","first-page":"1278","article-title":"Frame shift by insertion of 2 base pairs in codon 394 of CYP11B1 causes congenital adrenal hyperplasia due to steroid 11\u03b2-hydroxylase deficiency","volume":"75","author":"Helmberg","year":"1992","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1053\/beem.2000.0118_RF80","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1006\/bbrc.1995.2681","article-title":"Classic steroid 11\u03b2-hydroxylase deficiency caused by a C\u2192G transversion in exon 7","volume":"216","author":"Yang","year":"1995","journal-title":"Biochemical and Biophysical Research Communications"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X00901180?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X00901180?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:32:17Z","timestamp":1761496337000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X00901180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,3]]},"references-count":80,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2001,3]]}},"alternative-id":["S1521690X00901180"],"URL":"https:\/\/doi.org\/10.1053\/beem.2000.0118","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2001,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disorders of mineralocorticoid synthesis","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/beem.2000.0118","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2001 Harcourt Publishers Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}